• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类器官在胆管癌和胆囊癌中的应用及研究进展

Application and research progress of organoids in cholangiocarcinoma and gallbladder carcinoma.

作者信息

Huang Yun-Peng, Liu Kai, Wang Yong-Xiang, Yang Yang, Xiong Li, Zhang Zi-Jian, Wen Yu

机构信息

Department of General Surgery, The Second Xiangya Hospital of Central South University Changsha 410011, Hunan Province, China.

出版信息

Am J Cancer Res. 2021 Jan 1;11(1):31-42. eCollection 2021.

PMID:33520358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7840717/
Abstract

Both cholangiocarcinoma (CCA) and gallbladder carcinoma (GBC) are belong to biliary tract carcinomas (BTCs) with a high degree of malignancy and a poor prognosis. Therefore, an model is urgently needed to increase our understanding of the pathogenesis of BTCs. Tumor organoids are a novel three-dimensional (3D) culture technology that utilizes samples from removed tumors. Therefore, it can maintain the histological features, expression profiles and marker expression of the parental tissues. Recently, with the widespread use of this technique, increasing research is beginning to use organoid to study the cellular metabolism, pathogenesis, chemotherapy resistance, and new therapy methods of BTCs. In this review, we will discuss the advantages and disadvantages of BTC organoids compared with other cell culture techniques. In addition, the construction methods, research directions and current limitations of BTC organoids will be described.

摘要

胆管癌(CCA)和胆囊癌(GBC)均属于恶性程度高、预后差的胆道癌(BTC)。因此,迫切需要一个模型来增进我们对BTC发病机制的理解。肿瘤类器官是一种利用切除肿瘤样本的新型三维(3D)培养技术。因此,它可以维持亲代组织的组织学特征、表达谱和标志物表达。近年来,随着这项技术的广泛应用,越来越多的研究开始使用类器官来研究BTC的细胞代谢、发病机制、化疗耐药性和新的治疗方法。在这篇综述中,我们将讨论BTC类器官与其他细胞培养技术相比的优缺点。此外,还将描述BTC类器官的构建方法、研究方向和当前局限性。

相似文献

1
Application and research progress of organoids in cholangiocarcinoma and gallbladder carcinoma.类器官在胆管癌和胆囊癌中的应用及研究进展
Am J Cancer Res. 2021 Jan 1;11(1):31-42. eCollection 2021.
2
Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma.胆管癌患者来源类器官的建立与药物筛选。
Cell Rep. 2019 Apr 23;27(4):1265-1276.e4. doi: 10.1016/j.celrep.2019.03.088.
3
Expression of fatty-acid-binding protein 5 in intrahepatic and extrahepatic cholangiocarcinoma: the possibility of different energy metabolisms in anatomical location.脂肪酸结合蛋白5在肝内和肝外胆管癌中的表达:解剖部位不同能量代谢的可能性
Med Mol Morphol. 2020 Mar;53(1):42-49. doi: 10.1007/s00795-019-00230-9. Epub 2019 Aug 20.
4
MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K/AKT pathway.微小RNA-451a通过抑制巨噬细胞移动抑制因子介导的PI3K/AKT信号通路来抑制吉西他滨难治性胆管癌的进展。
Mol Ther Nucleic Acids. 2023 Oct 28;34:102054. doi: 10.1016/j.omtn.2023.102054. eCollection 2023 Dec 12.
5
Recent Advances in the Mechanism Research and Clinical Treatment of Anti-Angiogenesis in Biliary Tract Cancer.胆管癌抗血管生成机制研究与临床治疗的最新进展
Front Oncol. 2021 Oct 28;11:777617. doi: 10.3389/fonc.2021.777617. eCollection 2021.
6
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review.可切除胆管癌围手术期治疗的现状与未来展望:多学科综述
Cancers (Basel). 2021 Apr 1;13(7):1647. doi: 10.3390/cancers13071647.
7
Understanding the Clinical Significance of MUC5AC in Biliary Tract Cancers.了解MUC5AC在胆道癌中的临床意义。
Cancers (Basel). 2023 Jan 9;15(2):433. doi: 10.3390/cancers15020433.
8
Immunotherapy of biliary tract cancer.胆管癌的免疫治疗
Tumour Biol. 2016 Mar;37(3):2817-21. doi: 10.1007/s13277-015-4743-x. Epub 2016 Jan 4.
9
[Biliary tract cancers : Molecular characterization and identification of novel prognostic markers].[胆道癌:分子特征及新型预后标志物的鉴定]
Pathologe. 2017 Nov;38(Suppl 2):192-197. doi: 10.1007/s00292-017-0359-9.
10
Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine.胆管癌的分子与免疫特征:向个性化医疗的范式转变
Cancers (Basel). 2020 Aug 6;12(8):2190. doi: 10.3390/cancers12082190.

引用本文的文献

1
Dynamic gene expression pattern in zebrafish gallbladder: an experimental study.斑马鱼胆囊中的动态基因表达模式:一项实验研究。
Int J Surg. 2024 Dec 1;110(12):7585-7589. doi: 10.1097/JS9.0000000000002135.
2
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.探索诱导多能干细胞在癌症研究和治疗中的广阔前景。
Mol Cancer. 2023 Nov 28;22(1):189. doi: 10.1186/s12943-023-01873-0.
3
CircTP63 promotes cell proliferation and invasion by regulating EZH2 via sponging miR-217 in gallbladder cancer.环状TP63通过在胆囊癌中充当miR-217的海绵来调控EZH2,从而促进细胞增殖和侵袭。
Cancer Cell Int. 2021 Nov 17;21(1):608. doi: 10.1186/s12935-021-02316-w.
4
Central nervous system tumors and three-dimensional cell biology: Current and future perspectives in modeling.中枢神经系统肿瘤与三维细胞生物学:建模的现状与未来展望
World J Stem Cells. 2021 Aug 26;13(8):1112-1126. doi: 10.4252/wjsc.v13.i8.1112.
5
Sulfasalazine Sensitizes Polyhematoporphyrin-Mediated Photodynamic Therapy in Cholangiocarcinoma by Targeting xCT.柳氮磺胺吡啶通过靶向xCT使胆管癌对多血卟啉介导的光动力疗法敏感。
Front Pharmacol. 2021 Aug 13;12:723488. doi: 10.3389/fphar.2021.723488. eCollection 2021.
6
A case of idiopathic retroperitoneal fibrosis presenting as gallbladder carcinoma.特发性腹膜后纤维化致胆囊癌 1 例报告
BMC Surg. 2021 Mar 25;21(1):162. doi: 10.1186/s12893-021-01162-x.

本文引用的文献

1
Establishment and characterization of breast cancer organoids from a patient with mammary Paget's disease.乳腺佩吉特病患者乳腺癌类器官的建立与表征
Cancer Cell Int. 2020 Aug 3;20:365. doi: 10.1186/s12935-020-01459-6. eCollection 2020.
2
Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing.患者来源的卵巢癌细胞类器官可捕获原发肿瘤的基因组特征,适用于药物敏感性和耐药性检测。
Sci Rep. 2020 Jul 28;10(1):12581. doi: 10.1038/s41598-020-69488-9.
3
Early pathogenesis of cystic fibrosis gallbladder disease in a porcine model.囊性纤维化胆囊疾病的早期发病机制在猪模型中的研究。
Lab Invest. 2020 Nov;100(11):1388-1399. doi: 10.1038/s41374-020-0474-8. Epub 2020 Jul 27.
4
Modeling neoplastic disease with spheroids and organoids.用球体和类器官模拟肿瘤疾病。
J Hematol Oncol. 2020 Jul 16;13(1):97. doi: 10.1186/s13045-020-00931-0.
5
Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses.患者来源的卵巢癌细胞类器官模拟临床应答并表现出异质性的肿瘤内和肿瘤间药物反应。
Cell Rep. 2020 Jun 16;31(11):107762. doi: 10.1016/j.celrep.2020.107762.
6
Biliary Tract Cancer: Current Medical Treatment Strategies.胆道癌:当前的医学治疗策略
Cancers (Basel). 2020 May 14;12(5):1237. doi: 10.3390/cancers12051237.
7
Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity.从多个结直肠癌肝转移患者来源的类器官中揭示中等程度的患者内药物代谢转录组学异质性。
Clin Cancer Res. 2020 Aug 1;26(15):4107-4119. doi: 10.1158/1078-0432.CCR-19-3637. Epub 2020 Apr 16.
8
Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer.Hippo-YAP1是晚期胆囊癌的预后标志物和潜在可靶向通路。
Cancers (Basel). 2020 Mar 25;12(4):778. doi: 10.3390/cancers12040778.
9
Mitochondrial Fusion Via OPA1 and MFN1 Supports Liver Tumor Cell Metabolism and Growth.OPA1 和 MFN1 通过线粒体融合支持肝癌细胞代谢和生长。
Cells. 2020 Jan 4;9(1):121. doi: 10.3390/cells9010121.
10
Emerging organoid models: leaping forward in cancer research.新兴类器官模型:癌症研究的飞跃。
J Hematol Oncol. 2019 Dec 29;12(1):142. doi: 10.1186/s13045-019-0832-4.